All In Biotech

Free tool

FAERS Monitor: Depo-Provera

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020246 or its brand name (Depo-Provera, Medroxyprogesterone Acetate). Reports on generic versions are filed under their own applications.

Reports

32,474

Serious

27,392

84% of reports

Hospitalization

3,238

Death reported

486

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • meningioma12,292
  • breast cancer female3,020
  • breast cancer1,857
  • drug ineffective922
  • headache780
  • nausea777
  • pain699
  • weight increased697
  • depression652
  • unintended pregnancy647
  • meningioma benign637
  • off label use607
  • fatigue603
  • dizziness558
  • anxiety517

Reports by year received

View as table
YearReports
20041,555
20051,470
20061,242
2007463
2008433
2009850
20102,477
20111,191
2012807
2013495
2014570
2015756
2016856
2017505
2018463
2019711
2020573
2021463
2022759
2023742
2024919
20252,674
202611,499

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,021,685 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
meningiomaSignal12,2922383.12297.36,256,229
meningioma benignSignal6371412.21230.0281,913
breast cancer femaleSignal3,02082.479.5215,677
unintended pregnancySignal64742.739.424,680
breast cancerSignal1,85713.112.620,505
weight increasedSignal6972.01.9360
depression6521.91.7260
anxiety5171.21.114
headache7800.80.837
pain6990.70.767
dizziness5580.70.760
nausea7770.60.6168
fatigue6030.50.5310
drug ineffective9220.50.4650
off label use6070.40.4428

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.